• Skip to content
  • Skip to footer
  • Accessibility options
University of Brighton
  • About us
  • Business and
    employers
  • Alumni and
    supporters
  • For
    students
  • For
    staff
  • Accessibility
    options
Open menu
Home
Home
  • Close
  • Study
    • Courses and subjects
    • Find a course
    • A-Z course list
    • Explore our subjects
    • Academic departments
    • Visiting the university
    • Explore online
    • Online events
    • Virtual tours
    • Chat to our students and staff
    • Open days
    • Applicant days
    • Order a prospectus
    • Ask a question
    • Studying here
    • Clearing 2021
    • Accommodation and locations
    • Applying
    • Undergraduate
    • Postgraduate
    • Transferring from another university
    • The Student Contract
    • International students
    • Fees and finance
    • Advice and help
    • Advice for students
    • Advice for parents and carers
    • Advice for schools and teachers
    • Managing your application
    • Undergraduate
    • Postgraduate
  • Research and enterprise
    • Research and enterprise
    • Research and enterprise organisation
    • Brighton Futures – our themes
    • Centres of Research and Enterprise Excellence (COREs)
    • Research and Enterprise Groups (REGs)
    • Our research database
    • Information for business
    • Community University Partnership Programme (CUPP)
    • Postgraduate research degrees
    • PhD research disciplines and programmes
    • PhD funding opportunities and studentships
    • How to apply for your PhD
    • Research environment
    • Investing in research careers
    • Strategic plan
    • Research concordat
    • News, events, publications and films
    • Research and enterprise news
    • Research and enterprise public events
    • Inaugural lectures
    • Research publications and films
    • Academic staff search
  • About us
  • Business and employers
  • Alumni, supporters and giving
  • Current students
  • Staff
  • Accessibility
Search our site
Strand-banner-image
Centre for Stress and Age-Related Disease
  • What we do
  • Who we work with
  • Study or work with us
  • Who we are
  • What we do
    • What we do
    • Cell biology
    • Chemical biology
    • Our research and enterprise impact
    • Our research and enterprise projects
    • Translational sciences
  • Our research and enterprise projects
    • Our research and enterprise projects
    • A computational protocol to model organophosphonate CWAs and their simulants
    • A reactive oxygen and nitrogen species monitoring system to study their role in cancer
    • Amphiphilic-polymer-based-enhancers-for-local-drugs-delivery-to-the-inner-ear
    • Antibiotic efficacy in treating wound infection
    • Antioxidative enzymes
    • BK channels as Pharmacological targets for therapeutic intervention
    • Clinically reflective cellular model systems for Type 1 diabetes
    • Combating disorders of CNS myelination
    • Controlling infection in urinary catheters
    • C-Stress project
    • Development of a novel platform for local targeted treatment of cardiovascular disease
    • Development of an infection detecting wound dressing
    • Effects of age on signalling and function in the lower bowel
    • Effects of age on the central nervous system
    • Electrochemical sensor devices to understand ageing and disease mechanisms
    • Exploiting genomics to understand the role of vitamin D in human health and metabolism
    • Exploring the role of ADRB2 in triple negative breast cancer
    • Faecal sensor
    • Galactosemia – protein misfolding diseases which result in cellular stress
    • Hepatic disease
    • HIIT for Health
    • Identifying small molecules to remove or modify the phenotype of ageing cells
    • Increasing insulin production
    • Infection detecting wound dressing
    • Inflammation and Immunity
    • Modelling of cellular phospholipid homeostasis
    • Novel explanation for NSAID-induced cardiovascular side effects
    • organ of Corti
    • Pancreatic islet cell replacement and transplantation
    • PHOTORELEASE
    • Pillar(5)arenes
    • PPARβδ control of inflammation
    • Probing ion transport mechanisms with synthetic ion channels
    • Proteomic and genomic analysis of cellular stress responses
    • Quantifying-a-biophysical-model-of-lipid-protein
    • SensoPellet
    • Sex determination of human remains from peptides in tooth enamel
    • Stress hormones in BRCA mutation carriers
    • Switchable Molecules: A Radical Approach
    • Switchable surfactants in drug delivery
    • Synthesis and evaluation of Resveratrol derivatives
    • The effects of pre-natal alcohol on adolescent learning and memory
    • Translational regulation of stress responses and antibiotic production in Streptomyces bacteria
    • Type 1 Diabetes – cause and cure
    • Type 2 Diabetes
    • Understanding how social isolation increases morbidity and mortality
  • Novel explanation for NSAID-induced cardiovascular side effects

Novel explanation for NSAID induced cardiovascular side effects

Non-steroidal anti-inflammatory drugs (NSAIDS) inhibit cyclooxygenase (COX), the enzymes that reduce prostaglandin production. There are two isoforms, COX-1 which is constitutively expressed, and COX-2 which is inducible. NSAIDS are widely used for their analgesic, antipyretic and anti-inflammatory properties however despite their therapeutic effectiveness, their use has been widely scrutinised due to their tendency to produce side effects. Since prostaglandins protect the gastrointestinal tract and are important in platelet aggregation, NSAID reduction of prostanoids increases the risk of gastrointestinal ulceration and bleeds. Clinical trials revealed the side effects of both pan and COX-1 sparing NSAIDs led to gastrointestinal damage and cardiovascular complications including myocardial infarction. COX-2 selective drugs (such as celecoxib and rofecoxib) were developed to avoid gastrointestinal damage.

While much debate about the CV side effects of NSAIDs has concentrated on the direct effects of NSAIDs on COX activity, this project aims to investigate the indirect CV side effects of NSAIDs and related compounds. This follows on from a pilot study conducted at the University of Hertfordshire where in silico modelling of celecoxib and diclofenac indicated a potential for both drugs to associate with thyroid hormone receptor β (TRβ), and further analysis using in vitro methods indicate that both celecoxib and diclofenac and not naproxen possess TRβ antagonistic properties. This nuclear receptor is of great interest, with clear relationships between hypothyroidism associated with increased heart muscle stiffness and an increased risk of myocardial infarction. 

 

Project timeframe

The project commenced in 2013.

Project aims

  1. Confirm predicted interactions with specific nuclear receptor luciferase reporter assays.
  2. Using in vitro assays, determine whether NSAID interaction with other receptors (as determined by computational chemistry methods) interferes with normal cell function.
  3. Measure effects of NSAIDs in endocrine systems.

Project findings and impact

Output, findings and impact will be updated in due course.

Research team

Dr Louise Mackenzie

Dr Prabel Chatterjee

Output

LS MACKENZIE. Thyroid Hormone Receptor Antagonists; from Environmental Pollution to Novel Small Molecules. THYROID HORMONE (Academic Press/Elsevier) Vitam Horm. 106:147-162 (2018)

Zloh, M., Perez-Diaz, N., Tang, L., Patel, P. & Mackenzie, L.S. Evidence that Diclofenac and Celecoxib are thyroid hormone receptor beta antagonists. Life sciences; 1;146: 66-72 (2016)

Perez-Diaz, N., Zloh, M., Tang, L., Patel, P. & Mackenzie, L.S. Evidence that Diclofenac and Celecoxib are  Thyroid Hormone Receptor Beta Antagonists; use of in silico, molecular and pharmacological techniques. pA2 Online. Vol 13, iss 3, 246 (2015)

Ahmetaj-Shala, B., Kirkby, N. S., Knowles, R., Al'Yamani, M., Mazi, S., Wang, Z., Tucker, A. T., Mackenzie, L. S., Armstrong, P. C. J., Nüsing, R. M., Tomlinson, J. A. P., Warner, T. D., Leiper, J. & Mitchell, J. A. Reply to Letter Regarding Article, "Evidence That Links Loss of Cyclooxygenase-2 With Increased Asymmetric Dimethylarginine: Novel Explanation of Cardiovascular Side Effects Associated With Anti-Inflammatory Drugs. Circulation. 131, 7, p. 633-42 10 p (2015)

Kirkby, N., Chan, M. V., Lundberg, M. H., MacKenzie, L.S., Leadbeater, P. D. M., Milne, G. L., Potter, C. M., Al-Yamani, M., Adeyemi, O., Warner, T. D. & Mitchell, J. A. Aspirin triggered 15-epi-lipoxin A4 predicts cyclo-oxygenase-2 in the lungs of LPS treated mice but not in the circulation: implications for a clinical test. FASEB Journal. 27, p. 3938-46

Kirkby, N. S., Zaiss, A. K., Urquhart, P., Jiao, J., Austin, P. J., Al-Yamani, M., Lundberg, M. H., MacKenzie, L.S., Warner, T. D., Nicolaou, A., Herschman, H. R. & Mitchell, J. A. LC-MS/MS Confirms That COX-1 Drives Vascular Prostacyclin Whilst Gene Expression Pattern Reveals Non-Vascular Sites of COX-2 Expression. PLoS ONE. 8, 7, e69524

Kirkby, N. S., Lundberg, M. H., Harrington, L. S., Leadbeater, P. D. M., Potter, C. M. F., Al-Yamani, M., Adeyemi, O., Mitchell, J. A., Warner, T. D. & Milne, G. L. Cyclooxygenase-1, not cyclooxygenase-2, is responsible for physiological production of prostacyclin in the cardiovascular system. Proceedings of the National Academy of Sciences. 109, 43, p. 17597-17602 6 p. Joint first Author. Erratum in PNAS Jan 2013; 110(4):1561 

Potter, C. M. F., Lundberg, M. H., Harrington, L. S., Moshkov, A. V., Gorelik, J., Mitchell, J. A., Warboys, C. M., Weinberg, P. D., Warner, T. D. & Berson, R. E. Role of shear stress in endothelial cell morphology and expression of cyclooxygenase isoforms. Arteriosclerosis, Thrombosis, and Vascular Biology. 31, 2, p. 384-391 8 p.

Partners

Mr Gary Dolan (University of Hertfordshire)

Emeritus Professor Mire Zloh (University of Hertfordshire)

Dr Lisa Lione (University of Hertfordshire)

Prof Jane Mitchell (Imperial College)

Dr Nick Kirkby (Imperial College)

Back to top
  • Facebook
  • Twitter
  • Instagram
  • YouTube
  • LinkedIn icon

Contact us

University of Brighton
Mithras House
Lewes Road
Brighton
BN2 4AT

Main switchboard 01273 600900

Course enquiries

Sign up for updates

University contacts

Report a problem with this page

Quick links

  • Courses
  • Open days
  • Order a prospectus
  • Academic departments
  • Academic staff
  • Professional services departments
  • Jobs
  • Privacy and cookie policy
  • Accessibility statement
  • Libraries
  • Term dates
  • Maps
  • Graduation
  • Site information
  • Online shop
  • COVID-19

Information for

  • Current students
  • International students
  • Media/press
  • Careers advisers/teachers
  • Parents/carers
  • Business/employers
  • Alumni/supporters
  • Suppliers
  • Local residents